Biography
SAM ZUCKER advises high-growth and emerging life sciences, healthcare, and technology companies, as well as their investors and investment banks on corporate and capital markets transactions globally.
Sam has extensive experience representing companies and investors in venture capital, startup, and private equity financings. He also advises issuers and investment banks on public company securities offerings, including the primary methods of going public (including initial public offerings, reverse mergers, SPAC, and de-SPAC transactions), and public company financings (including follow-on offerings, confidentially marketed public offerings, registered direct offerings, private investments in public equity, at-the-market offerings, and convertible debt). He advises buyers and sellers in mergers and acquisitions, joint ventures, strategic alliances, divestitures, and change in control transactions.
Sam counsels clients on regulatory matters involving the U.S. Securities and Exchange Commission (SEC) and Nasdaq. He also advises management teams and boards of directors on corporate governance, public company reporting, market regulatory matters, acquisitions, strategic transactions, corporate development, and capital markets strategies.
Sam has been nationally ranked by Chambers USA for California Life Sciences: Corporate/Commercial (2007–2026). He has also been recognized by The Best Lawyers in America® for Biotechnology and Life Sciences (2020–2026) and was named “Lawyer of the Year” for Biotechnology and Life Sciences in the San Francisco Bay Area (2021 and 2024).
Credentials
- 美国加州
- Yale Law School, 法学博士, 1995
- Columbia College, 文学学士, 1990